Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial

Treatment of iron overload using deferoxamine (DFO) is associated with significant deficits in patients' health-related quality of life (HRQOL) and low treatment satisfaction. The current article presents patient-reported HRQOL, satisfaction, adherence, and persistence data from β-thalassemia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, John, Bowden, Donald K., Economou, Marina, Troncy, Jacques, Ganser, Arnold, Habr, Dany, Martin, Nicolas, Gater, Adam, Rofail, Diana, Abetz-Webb, Linda, Lau, Helen, Cappellini, Maria Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424665/
https://www.ncbi.nlm.nih.gov/pubmed/22924125
http://dx.doi.org/10.1155/2012/297641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424665/
https://www.ncbi.nlm.nih.gov/pubmed/22924125
http://dx.doi.org/10.1155/2012/297641

Ejemplares similares